Billroth I, a Viable Alternative in Early Distal Gastric Cancers: Short-Term Results from an Indian Tertiary Care Center

Author(s):  
Kalyan Pandey ◽  
Padmalaya Devi ◽  
Prafulla Kumar Das ◽  
Swodeep Mohanty ◽  
Kunal Goutam ◽  
...  
2021 ◽  
Vol 47 (2) ◽  
pp. e50-e51
Author(s):  
Abhitesh Singh ◽  
Anshul Jain ◽  
Dillip Muduly ◽  
Mahesh Sultania ◽  
Jyoti Ranjan Swain ◽  
...  

2016 ◽  
Vol 7 (3) ◽  
pp. 345-353 ◽  
Author(s):  
Vishwas D. Pai ◽  
Sudhir Jatal ◽  
Vikas Ostwal ◽  
Reena Engineer ◽  
Supreeta Arya ◽  
...  

2018 ◽  
Vol 70 (2) ◽  
pp. 265-271 ◽  
Author(s):  
Stefano de Pascale ◽  
Daniele Belotti ◽  
Andrea Celotti ◽  
Eleonora Maddalena Minerva ◽  
Vittorio Quagliuolo ◽  
...  

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Umesh Lingaraj ◽  
Ricken Mehta ◽  
Shivaprasad SM ◽  
Leelavathi V ◽  
Kishan A ◽  
...  

Abstract Background and Aims Aims - To study the clinicopathological profile and short-term outcome of patients with Pauci-immune Glomerulonephritis at a tertiary care center Method Results In our study group we found that majority of the patients had RPGN presentation (93.3%). Conclusion


2021 ◽  
Vol 11 ◽  
pp. 10
Author(s):  
Abhinandan Ruge ◽  
Nidhi Kumar ◽  
Clyde Menezes

Objectives: The objective of this study was to evaluate the role of Gelfoam as an effective embolizing agent in patients with hemoptysis presenting to a tertiary care center in developing nations. Material and Methods: A retrospective analysis of data from 30 patients treated by Interventional radiologist at St. John’s Medical College, Bangalore, India, was performed. The study included 22 males (73.3%) and 8 (26.65%) female patients. Gelfoam was used as the sole embolizing agent and arteries with features of abnormal blush and hypertrophy were targeted. Analysis of the etiology, immediate, and short-term outcome and complications, when present, was performed. The median follow-up period was 45 days following an embolization procedure at this center. Results: A high short-term efficacy was noted following embolization procedures with Gelfoam as the sole agent. Twenty-eight out of 30 procedures were deemed successful, and post-tubercular changes were noted to be the cause for hemoptysis in 23 patients. The high short-term efficacy (93.3%), evidenced by a complete stoppage of hemoptysis, along with a relatively low rate of complications (spinal cord ischemia in only 2.3%), strengthens the position of Gelfoam as the sole embolizing agent in a resource-limited setting. Conclusion: In an economically constrained setting, Gelfoam proves to be a useful first choice single embolization agent, while polyvinyl alcohol particles coupled with microcatheter systems remain within reach of only those who can afford them.


Urology ◽  
2011 ◽  
Vol 78 (3) ◽  
pp. S121
Author(s):  
L. Kluth ◽  
R. Dahlem ◽  
P. Reiss ◽  
M. Rink ◽  
J. Hansen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document